Remedial Health, a Nigerian startup reshaping the pharmaceutical landscape, has amassed $12 million in a Series A equity-debt funding round. The funds aim to enhance operations within Nigeria, digitizing pharmacies and refining the pharmaceutical supply chain. Prominent fintech VC firm, QED Investors, co-led the round, demonstrating faith in the potential for embedded financial services like…